Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bioregenx (BRGX) Other Operating Expenses (2022 - 2025)

Bioregenx's Other Operating Expenses history spans 4 years, with the latest figure at $702343.0 for Q4 2025.

  • Quarterly results put Other Operating Expenses at $702343.0 for Q4 2025, down 95.81% from a year ago — trailing twelve months through Dec 2025 was $715924.0 (down 95.91% YoY), and the annual figure for FY2025 was $740924.0, down 96.01%.
  • Other Operating Expenses for Q4 2025 was $702343.0 at Bioregenx, up from $2316.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $16.8 million in Q4 2024 to a low of $2316.0 in Q3 2025.
  • The 4-year median for Other Operating Expenses is $64903.5 (2023), against an average of $1.2 million.
  • The sharpest move saw Other Operating Expenses soared 18770.95% in 2024, then tumbled 99.6% in 2025.
  • Year by year, Other Operating Expenses stood at $7686.0 in 2022, then surged by 1056.27% to $88871.0 in 2023, then soared by 18770.95% to $16.8 million in 2024, then tumbled by 95.81% to $702343.0 in 2025.
  • According to Business Quant data, Other Operating Expenses over the past three periods came in at $702343.0, $2316.0, and $2987.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.